NuVasive adds to its board of directors

Laura Dyrda -   Print  |

NuVasive, a spine technology company, added Siddhartha Kadia, PhD, to its board of directors effective Feb. 1.

Dr. Kadia was president and CEO of EAG Laboratories, a global scientific services company, and president of the life sciences division at Life Technologies, a biotech company that was acquired by Thermo Fisher Scientific in 2014.

In his new role on NuVasive's board, Dr. Kadia will help drive innovation and support the company's goal of transforming surgery. In January, a study published in The Spine Journal validated its single-position spine surgery with the X360 procedural approach as improving efficiency while reducing complications and hospital length of stay.

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers